ClinicalTrials.govpublic full text
Study of Oxaliplatin and Xeloda and Cetuximab as First Line Treatment for Metastatic or Unresectable Gastric or Gastroesophageal Junction Cancer
gastric cancer, esophageal cancer, gastroesophageal junction cancer, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 826414
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.